Migraine
326 results
1 - 100Oxcarbazepine does not prevent migraine
Dexamethasone does not prevent migraine recurrence
Fremanezumab effective for episodic migraine
Meperidine (pethidine) less effective for migraine
Acupuncture is effective for the prevention of migraine without aura
Acute migraine: prochlorperazine better than sumatriptan
Migraine with aura associated with increased risk of CVD in women
Specific headache criteria useful for migraine diagnose, neuroimaging
Topiramate and amitriptyline not effective for migraine in children (CHAMP trial)
Rimegepant somewhat effective for acute migraine (NNT = 13)
Yoga appears to be effective in reducing migraine intensity and frequency
Clinical practice guideline update for migraine prevention with medications
Atogepant prevents acute headaches in adults with chronic migraines
Triptans outperform older and newer treatments of acute migraine
Evidence review of medications for preventing migraines in children and adolescents
Intranasal zavegepant is moderately superior to placebo for acute migraine in adults
Guideline update for migraine prevention with NSAIDs, CAM, nontraditional treatments
CBT plus amitriptyline optimal for chronic migraine in children and adolescents
Yoga enhances conventional medical therapy in patients with episodic migraine
AAN Guidelines on medications for acute treatment and prevention of migraine in children and adolescents
What are the comparative benefits of available treatments for acute migraine pain?
Monoclonal antibody treatments for migraine are effective, well-tolerated, and expensive
Another "-gepant"—ubrogepant —is somewhat effective for acute migraine (NNT = 13)
Some nonpharmacological treatments may decrease migraine frequency in children and adolescents
Botulinum toxin A useful for chronic daily headaches and chronic migraines
Dexamethasone may prevent headache recurrence after treatment of acute migraine
Combo sumatriptan-naproxen slightly better than either alone for acute migraine
Erenumab decreases migraine frequency in patients who fail preventive therapies (LIBERTY)
Topical menthol 10% solution (peppermint oil) may abort acute migraine
Every other day use of rimegepant decreases migraine frequency by 1 per month
Ubrogepant modestly effective for acute migraine, but safety and a lack of comparison with triptans are concerning
IV metoclopromide in acute migraine: poor-quality data show it’s probably effective
Multiple randomized controlled trials fail to show the effectiveness of migraine chemoprophylaxis in children and adolescents
TENS more effective than sham TENS in decreasing pain in patients with acute migraine
Clopidogrel + aspirin better than aspirin alone to prevent migraines after ASD closure
A vibrating intranasal balloon catheter decreases short-term headache frequency in adults with chronic migraine
Noninvasive vagus nerve stimulation more effective than sham therapy for migraine attacks (PRESTO)
Ubrogepant during migraine prodrome is more effective than placebo to prevent moderate or severe headaches (NNT = 6)
Migraine prevention: Anti-CGRP monoclonal antibodies and onabotulinumtoxinA have similar rates of cardiovascular harm in older adults
Twenty percent of adults with chronic migraines need more than 12 weeks to respond to monoclonal antibodies against CGRP
Substituting n-3 (omega-3) fatty acids for n-6 fatty acids decreases headache days in patients with frequent migraines